Production (Stage)
Crinetics Pharmaceuticals, Inc.
CRNX
$31.32
-$0.455-1.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.42% | 142.42% | 55.53% | 226.22% | 204.25% |
| Total Receivables | -21.57% | -8.54% | -28.95% | -57.52% | 314.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 85.64% | 128.63% | 40.59% | 0.02% | 14.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.20% | 36.32% | -73.16% | -40.34% | -9.70% |
| Total Current Assets | 40.76% | 139.55% | 52.42% | 207.14% | 200.33% |
|
|
|||||
| Total Current Assets | 40.76% | 139.55% | 52.42% | 207.14% | 200.33% |
| Net Property, Plant & Equipment | -4.00% | -3.23% | -3.17% | 1,179.20% | 1,142.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 896.15% | -50.64% | 39.31% | -23.68% | -67.25% |
| Total Assets | 39.17% | 125.79% | 46.11% | 219.02% | 211.50% |
|
|
|||||
| Total Accounts Payable | -8.50% | -10.61% | -15.46% | 83.12% | 82.46% |
| Total Accrued Expenses | 28.66% | 62.69% | 66.84% | 123.08% | 73.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.84% | 71.39% | 85.84% | 571.33% | 436.79% |
| Total Finance Division Other Current Liabilities | -59.06% | -62.77% | -72.82% | -76.01% | 154.08% |
| Total Other Current Liabilities | -59.06% | -62.77% | -72.82% | -76.01% | 154.08% |
| Total Current Liabilities | 10.71% | 35.82% | 32.37% | 66.75% | 96.68% |
|
|
|||||
| Total Current Liabilities | 10.71% | 35.82% | 32.37% | 66.75% | 96.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.94% | -6.28% | -6.34% | 3,050.62% | 2,579.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.24% | 16.48% | 10.93% | -10.84% | -15.57% |
| Total Liabilities | 3.98% | 14.07% | 11.31% | 167.70% | 206.48% |
|
|
|||||
| Common Stock & APIC | 44.22% | 90.96% | 49.05% | 105.27% | 107.73% |
| Retained Earnings | -45.55% | -45.65% | -46.82% | -48.22% | -48.53% |
| Treasury Stock & Other | 1,234.67% | -1.43% | 335.61% | 88.86% | 105.97% |
| Total Common Equity | 43.33% | 145.74% | 52.07% | 226.92% | 212.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.33% | 145.74% | 52.07% | 226.92% | 212.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 43.33% | 145.74% | 52.07% | 226.92% | 212.11% |
|
|
|||||